Pliant Therapeutics PLRX
NASDAQ PLRX
$0.79 -0.01 (-1.74%)
At close: Nov 10, 2026 · 4:00 PM EST

Pliant Therapeutics (PLRX) Preferred Stock Liabilities (2019 - 2020)

Updated

Pliant Therapeutics (PLRX) recorded Preferred Stock Liabilities of $238.31 million in Q1 2020, up 27.9% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Pliant Therapeutics reported Preferred Stock Liabilities of $186.28 million.

  • Per Business Quant, the preceding three quarters came in at $186.28 million (Q4 2019), $136.18 million (Q3 2019) and $134.81 million (Q2 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Pliant Therapeutics 50.15 Mn -711.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 238.31 Mn
Dec 31, 2019 186.28 Mn
Sep 30, 2019 136.18 Mn
Jun 30, 2019 134.81 Mn
API Access

Pliant Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PLRX&period=max&api_key=YOUR_API_KEY